Skip to main
ASPN
ASPN logo

Aspen Aerogels (ASPN) Stock Forecast & Price Target

Aspen Aerogels (ASPN) Analyst Ratings

Based on 19 analyst ratings
Buy
Strong Buy 58%
Buy 32%
Hold 11%
Sell 0%
Strong Sell 0%

Bulls say

Aspen Aerogels reported record Energy Industrial revenue of $53.1 million in the fourth quarter, reflecting a significant year-over-year growth of 70%, primarily driven by increased capacity through an external manufacturing facility. The company also exceeded its revenue expectations for the year, achieving $453 million compared to a prior outlook of $350 million, which represents an impressive 90% increase year-over-year. With strategic cost reductions and a capital-light expansion plan in place, Aspen is positioned to enhance profitability and generate positive cash flow, supporting future growth initiatives and potential shareholder returns.

Bears say

Aspen Aerogels Inc. is facing a challenging financial outlook, as indicated by a projected decline in Thermal Barrier revenue to $240 million in 2024, down from $306.8 million. Additionally, the company's revised forecasts for 2025 revenue and EBITDA suggest a significant drop from previous estimates, reflecting weak first-quarter guidance and uncertainty around General Motors' production volumes. The reliance on a limited number of customers for revenue, coupled with potential supply chain issues and competitive pressures, presents further risks that could adversely impact Aspen Aerogels's financial stability.

Aspen Aerogels (ASPN) has been analyzed by 19 analysts, with a consensus rating of Buy. 58% of analysts recommend a Strong Buy, 32% recommend Buy, 11% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aspen Aerogels and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aspen Aerogels (ASPN) Forecast

Analysts have given Aspen Aerogels (ASPN) a Buy based on their latest research and market trends.

According to 19 analysts, Aspen Aerogels (ASPN) has a Buy consensus rating as of Aug 2, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $19.47, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $19.47, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aspen Aerogels (ASPN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.